Ongoing Research L-Carnitine remains an active area of investigation across metabolism, exercise science, cardiovascular physiology, aging research, and mitochondrial biology
We founded Real Peptides because we were frustrated with the lack of transparency and quality in the research peptide space
Much of the blood pressure and cholesterol gap between people with obesity and everyone else has narrowed, and generics did that work, not the injectables
GLP-1 medications mimic this natural hormone and make its effects much stronger, which helps to: Slow gastric emptying Increase feelings of fullness Reduce appetite and cravings, which lowers calorie intake Improve insulin sensitivity Lower blood sugar levels Because people usually feel less hungry and eat fewer calories while taking GLP-1s, they typically lead to weight loss and improved metabolic health
Presented for research literature review only Wang ZY et al
Specific benefits for people with high blood pressure include: Weight reduction : Weight loss varies by agent and dosemore substantial with higher doses of semaglutide (Wegovy) for obesity management, and more modest with standard diabetes doses of GLP-1 agonists Reduced arterial stiffness : Some studies suggest GLP-1 agonists may improve vascular function Kidney effects : Some GLP-1 agonists have shown benefits in reducing albuminuria and slowing kidney disease progression, though SGLT2 inhibitors are generally preferred for kidney protection in diabetes [10] [19] Reduced cardiovascular events : The overall reduction in heart attacks and strokes benefits people with hypertension However, it is important to understand the potential risks and side effects